Ivan Scandale
Geneve, GE, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Consensus framework for developing a target product profile of real-time PCR in Chagas disease therapeutic monitoring.
Journal: PLoS neglected tropical diseases
Published: July 09, 2026
A Phase IIa, Proof-of-Concept, Placebo-Controlled, Randomised Trial to Investigate the Efficacy and Safety of Oxfendazole as a Macrofilaricidal Drug in Adults Harbouring Lymphatic Filarial Worms.
Journal: Infectious diseases and therapy
Published: April 02, 2026
A serological method's ability to distinguish treatment regimens by assessing early antibody decline in Chagas patients: insights from E1224 data.
Journal: The Journal of infectious diseases
Published: March 13, 2026
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers.
Journal: Antimicrobial agents and chemotherapy
Published: February 18, 2026
Population pharmacokinetics of DNDI-6148 in healthy adults.
Journal: PLoS neglected tropical diseases
Published: November 03, 2025
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African Adults.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 25, 2025
Population pharmacokinetic-pharmacodynamic analysis of benznidazole monotherapy and combination therapy with fosravuconazole in chronic Chagas disease (BENDITA).
Journal: PLoS neglected tropical diseases
Published: April 15, 2025
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas disease.
Journal: PLoS neglected tropical diseases
Published: September 24, 2024
A guide for the generation of repositories of clinical samples for research on Chagas disease.
Journal: PLoS neglected tropical diseases
Published: August 15, 2024
Further preclinical characterization of molnupiravir against SARS-CoV-2: Antiviral activity determinants and viral genome alteration patterns.
Journal: Heliyon
Published: January 09, 2024
Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains.
Journal: Antiviral research
Published: November 28, 2023
Last Updated: 09/26/2026